You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FOLR3

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Canada, United States (Mirvetuximab soravtansine)

Completed
Has Results
  • Tumors
  • Mirvetuximab soravtansine
  • Fairway, Kansas
  • +11 more
Jan 27, 2021

Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

Recruiting
  • Folate
  • +2 more
    • Nantong, China
      Affliated Hospital of Nantong University
    Dec 13, 2021

    Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

    Not yet recruiting
    • Ovarian Cancer
    • +4 more
    • (no location specified)
    May 12, 2023

    Epithelial Ovarian Cancer, NSCLC, Renal Cell Carcinoma Trial in Saint Louis, New York (ITIL-306)

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • ITIL-306
    • Saint Louis, Missouri
    • +1 more
    Aug 15, 2022

    Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

    Not yet recruiting
    • Ovary Cancer
    • +2 more
    • Aurora, Colorado
      University of Colorado Hospital
    May 30, 2023

    High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

    Not yet recruiting
    • High Grade Ovarian Cancer
    • +2 more
    • (no location specified)
    Jul 11, 2022

    Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Mirvetuximab Soravtansine
    • Bengbu, Anhui, China
    • +27 more
    Nov 14, 2022

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Mirvetuximab soravtansine
    • Anchorage, Alaska
    • +55 more
    Jul 25, 2022

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • New Orleans, Louisiana
    • +3 more
    Dec 16, 2022

    Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

    Recruiting
    • Ovarian Cancer
    • +2 more
    • mirvetuximab soravtansine (MIRV; IMGN853)
    • Birmingham, Alabama
      University of Alabama at Birmingham Womens & Infants Center
    Jun 30, 2022

    Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

    Not yet recruiting
    • Platinum-resistant Ovarian Cancer
    • +6 more
    • Pegylated Liposomal Doxorubicin + SL-172154
    • Mirvetuximab + SL-172154
    • (no location specified)
    Jul 29, 2022

    Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

    Completed
    • Epithelial Ovarian Cancer
    • +2 more
    • Mirvetuximab Soravtansine
    • Phoenix, Arizona
    • +88 more
    Jan 19, 2023

    Solid Tumor Trial in Guangzhou, Tianjin (CBP-1018)

    Not yet recruiting
    • Solid Tumor
    • Guangzhou, Guangdong, China
    • +1 more
    Jun 15, 2021